|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00455 TIANDA PHARMA
Nominal 
0.105 +0.002 (+1.942%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/09 HKD(K$) | |
| Turnover | 164,222 | 20.190% | 136,635 | 156,073 | 303,484 | 249,856 |
| Cost of Sales | (98,078) | 22.519% | (80,051) | (80,228) | (148,387) | (127,668) |
| Gross Profit | 66,144 | 16.895% | 56,584 | 75,845 | 155,097 | 122,188 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (31,237) | -7.926% | (33,926) | (25,200) | (5,569) | (20,197) | |
| Taxation | (985) | -- | 425 | (2,025) | 658 | 1,073 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (28) | -- | 264 | (11) | 784 | 2,775 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (32,250) | -2.970% | (33,237) | (27,236) | (4,127) | (16,349) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/09 HKD(K$) | |
| Net Finance Costs / (Income) | 2,117 | 15.936% | 1,826 | 2,433 | 2,476 | 3,282 |
| Depreciation & Amortisation | 20,486 | 8.489% | 18,883 | 18,570 | 17,638 | 19,223 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/09 | |
| EPS (cts) | -1.500 | -3.226% | -1.550 | -1.270 | -0.190 | -0.760 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.205 | -- | 0.226 | 0.253 | 0.280 | 0.300 |
| Remarks: | Real time quote last updated: 11/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -32,250 |
| %Change | -2.970% |
| EPS / (LPS) | HKD -0.015 |
| NBV Per Share ($) | HKD 0.205 |